News and Events
Stay informed about upcoming events, current clinical trials, and the latest information on PSC.
PSC Partners Canada’s newsletter “The Loon Duct” provides updates on initiatives, research, events, and other information impacting the PSC community in Canada.
Canadian non-profit Conscience announces a PSC project that has been approved for its Developing Medicines through Open Science (DMOS) program. The DMOS program PSC grantees are working towards treatments and cures for PSC.
PSC Partners announces the first patient enrolled in the WIND-PSC Study, a global prospective cohort to support the development of new treatments for primary sclerosing cholangitis.
Media Release The “What the Cell?!” event brought scientists and patients together to collaborate to translate basic science to the rare disease patient community.
PSC Partners Seeking a Cure is one of five patient-led rare disease groups in a CZI Study focused on clarifying the cellular mechanisms of pediatric PSC.
DENVER (Colo.) and TORONTO (Ont.) – Nonprofits worldwide are recognizing Global PSC Awareness Day on October 29, 2022, to increase awareness for the rare liver disease primary sclerosing cholangitis (PSC), which affects approximately one in 10,000 people worldwide.
PSC Partners announces the first patient enrolled in the WIND-PSC Study, a global prospective cohort to support the development of new treatments for primary sclerosing cholangitis.
The “What the Cell?!” event brought scientists and patients together to collaborate to translate basic science to the rare disease patient community.
PSC Partners Seeking a Cure is one of five patient-led rare disease groups in a CZI Study focused on clarifying the cellular mechanisms of pediatric PSC.
DENVER (Colo.) and TORONTO (Ont.) – Nonprofits worldwide are recognizing Global PSC Awareness Day on October 29, 2022, to increase awareness for the rare liver disease primary sclerosing cholangitis (PSC), which affects approximately one in 10,000 people worldwide.
PSC Partners Canada’s newsletter “The Loon Duct” provides updates on initiatives, research, events, and other information impacting the PSC community in Canada.
Canadian non-profit Conscience announces a PSC project that has been approved for its Developing Medicines through Open Science (DMOS) program. The DMOS program PSC grantees are working towards treatments and cures for PSC.
Stay updated on the latest news and events at PSC Partners Canada. From our upcoming events to media coverage of our work, we’re committed to keeping the Canadian PSC community informed.
PSC Partners Canada’s newsletter “The Loon Duct” provides updates on initiatives, research, events, and other information impacting the PSC community in Canada.
Canadian non-profit Conscience announces a PSC project that has been approved for its Developing Medicines through Open Science (DMOS) program. The DMOS program PSC grantees are working towards treatments and cures for PSC.
PSC Partners announces the first patient enrolled in the WIND-PSC Study, a global prospective cohort to support the development of new treatments for primary sclerosing cholangitis.
The “What the Cell?!” event brought scientists and patients together to collaborate to translate basic science to the rare disease patient community.
PSC Partners Seeking a Cure is one of five patient-led rare disease groups in a CZI Study focused on clarifying the cellular mechanisms of pediatric PSC.
DENVER (Colo.) and TORONTO (Ont.) – Nonprofits worldwide are recognizing Global PSC Awareness Day on October 29, 2022, to increase awareness for the rare liver disease primary sclerosing cholangitis (PSC), which affects approximately one in 10,000 people worldwide.
